FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes

Why did the Fed cut interest rates today? How will the Fed rate cut affect mortgages? What caused Cracker Barrel’s customer decline? Why is Nvidia banned from selling AI chips in China? How did Trump’s UK visit impact US-UK tech deal? Why did Ben & Jerry’s co-founder quit? What’s behind the surge in AI startup funding?

FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes

pbs.org/newshour/health/fda-takes-aim-at-telehealth-companies-for-promoting-unofficial-weight-loss-drug-dupes

The Food and Drug Administration on Tuesday posted more than 100 letters to various drugmakers and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered around lower-cost versions of blockbuster obesity injections.

This story appeared on pbs.org, 2025-09-17 15:16:50.